Desidustat in the Treatment of Anemia in CKD on Dialysis Patients
Status:
Active, not recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
A phase 3, multicenter, open-label, randomized, active-controlled study to evaluate the
efficacy and safety of Desidustat Tablet versus Epoetin alfa Injection for the treatment of
anemia in patients with CKD on dialysis. (DREAM-D)